首页> 外文期刊>麻酔 >デクスメデトミジン(dexmedetomidine)
【24h】

デクスメデトミジン(dexmedetomidine)

机译:Dexmedetomidine(Dexmedetomidine)

获取原文
获取原文并翻译 | 示例
       

摘要

Dexmedetomidine,a potent and highly selective alpha_2-agonist, provides a unique "conscious sedation"(patients appear to be asleep,but are readily roused),analgesia, without respiratory depression. In order to provide a comfortable sedation to the ICU patients,careful evaluation of sedation and analgesia level,and the consistent treatment by medical teams are necessary.We may expect the usefulness of dexmedetomidine in the settings other than the ICU, from its pharmacological properties Clinical applications of dexmedetomidine for several procedures such as awake craniotomy,fiberoptic tracheal intubation, or MRI examination have been reported, suggesting its usefulness and problems. The major problem with dexmedetomidine is its hemodynamic effects.Because this drug often causes hypotension,hypertension and bradycardia, it should be used under the control by skilled medical teams.
机译:德克梅托咪啶,一种有效和高精度的α_2-激动剂,提供了独特的“有意识的镇静”(患者似乎睡着,但易于唤醒),镇痛,没有呼吸抑郁症。 为了向ICU患者提供舒适的镇静,仔细评估镇静和镇痛水平,并且有必要的医疗团队的一致治疗。我们可能预计从其药理学特性临床的ICU以外的环境中的右丁嘌呤的有用性 据报道,Dexmedetomidine对诸如清醒的Craniotmy,纤维气管插管或MRI检查的若干程序的应用,表明其有用性和问题。 Dexmedetomidine的主要问题是其血流动力学作用。因为该药物常常导致低血压,高血压和心动过缓,它应该根据技术的医疗团队的控制。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号